The study of bone mineral density and bone turnover markers in postmenopausal women with active rheumatoid arthritis

References

• Deodhar A, Woolf A. Bone mass measurement and bone metabo-lism in rheumatoid arthritis. Br J Rheumatol 1996;35:309–22.
   PubMedGoogle Scholar
• Verstraeten A, Dequeker J. Vertebral and peripheral bone min-eral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids. Ann Rheum Dis 1986;45:852–7.
   PubMed Web of Science ®Google Scholar
• Huusko TM, Korpela M, Karppi P, Avikainen V, Kautiainen H, Sulkava R. Threefold increased risk of hip fractures with rheuma-toid arthritis in Central Finland. Ann Rheum Dis 2001;60:521–2.
   PubMed Web of Science ®Google Scholar
• Westhovens R, Dequeker J. Rheumatoid arthritis and osteoporo-sis. Z Rheumatol 2000;59:33–8.
   PubMedGoogle Scholar
• Gough A, Sambrook P, Devlin J, Huissoon A, Njeh C, Robbins S, et al. Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis. J Rheumatol 1998;25:1282–9.
   PubMed Web of Science ®Google Scholar
• Saag KG. Glucocorticoid-induced osteoporosis. Endocrinol Metab Clin North Am 2003;32:135–57.
   PubMed Web of Science ®Google Scholar
• Haugeberg G, Orstavik RE, Kvien TK. Effects of rheumatoid arthritis on bone. Curr Opin Rheumatol 2003;15:469–75.
   PubMed Web of Science ®Google Scholar
• Furumitsu Y, Inaba M, Yukioka K, Yukioka M, Kumeda Y, Azuma Y, et al. Levels of serum and synovial fluid pyridinium cross-links in patients with rheumatoid arthritis. J Rheumatol 2000;27:64–70.
   PubMedGoogle Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137–41.
   PubMed Web of Science ®Google Scholar
• Miller PD, Bonnick SL, Rosen CJ, Altman RD, Avioli LV, Dequeker J, et al. Clinical utility of bone mass measurements in adults: consensus of an international panel. The Society for Clinical Densitometry. Semin Arthritis Rheum 1996;25:361–72.
   PubMed Web of Science ®Google Scholar
• Sinigaglia L, Nervetti A, Mela Q, Bianchi G, Del Puente A, Di Munno 0, et al. A multicenter cross sectional study on bone min-eral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis. J Rheumatol 2000;27:2582–9.
   Google Scholar
• Kroger H, Tuppurainen M, Honkanen R, Alhava E, Saarikoski S. Bone mineral density and risk factors for osteoporosis - a population-based study of 1600 perimenopausal women. Calcif Tissue Int 1994;55: 1–7.
   Google Scholar
• Landin-Wilhelmsen K, Wilhelmsen L, Bengtsson BA. Postmeno-pausal osteoporosis is more related to hormonal aberrations than to lifestyle factors. Clin Endocrinol (Oxf) 1999;51:387–94.
   Google Scholar
• Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register. Arthritis Rheum 2000;43: 522–30.
   Google Scholar
• Michel BA, Bloch DA, Wolfe F, Fries JF. Fractures in rheumatoid arthritis: an evaluation of associated risk factors. J Rheumatol 1993;20:1666–9.
   PubMed Web of Science ®Google Scholar
• Forsblad D'Elia H, Larsen A, Waltbrand E, Kvist G, Mellstrom D, Saxne T, et al. Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalized os-teoporosis. Ann Rheum Dis 2003;62:617–23.
   PubMed Web of Science ®Google Scholar
• Orstavik RE, Haugeberg G, Uhlig T, Falch JA, HaIse JI, et al. Vertebral deformities in 229 female patients with rheumatoid arthritis: associations with clinical variables and bone mineral density. Arthritis Rheum 2003;49:355–60.
   PubMed Web of Science ®Google Scholar
• Seriolo B, Ferretti V, Sulli A, Caratto E, Fasciolo D, Cutolo M. Serum osteocalcin levels in premenopausal rheumatoid arthritis patients. Ann N Y Acad Sci 2002;966:502–7.
   PubMedGoogle Scholar
• Cortet B, Flipo RM, Pigny P, Duquesnoy B, Boersma A, Marchandise X, et al. Is bone turnover a determinant of bone mass in rheumatoid arthritis? J Rheumatol 1998;25:2339–44.
   PubMed Web of Science ®Google Scholar
• Gough AK, Peel NF, Eastell R, Holder RL, Lilley J, Emery P. Excretion of pyridinium cross-links correlates with disease activity and appendicular bone loss in early rheumatoid arthritis. Ann Rheum Dis 1994;53:14–7.
   PubMed Web of Science ®Google Scholar
• Valleala H, Laasonen L, Koivula MK, Mandelin J, Friman C, Ftisteli J, et al. Two year randomized controlled trial of etidronate in rheumatoid arthritis: changes in serum aminoterminal telopeptides correlate with radiographic progression of disease. J Rheumatol 2003;30:468–73.
   PubMed Web of Science ®Google Scholar
• Dykman TR, Gluck OS, Murphy WA, Hahn TJ, Hahn BH. Evalu-ation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum 1985;28:361–8.
   Google Scholar
• Laan FtF, van Ftiel PL, van Eming LJ, Lemmens JA, Ruijs SH, van de Putte LB. Vertebral osteoporosis in rheumatoid arthritis patients: effect of low dose prednisone therapy. Br J Rheumatol 1992;31:91–6.
   PubMedGoogle Scholar
• Laan FtF, van Ftiel PL, van de Putte LB, van Erning LJ, van 't Hof MA, Lemmens JA. Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A random-ized, controlled study. Ann Intern Med 1993;119:963–8.
   Google Scholar
• Sambrook PN, Cohen ML, Eisman JA, Pocock NA, Champion GD, Yeates MG. Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: a longitudinal study. Ann Rheum Dis 1989;48:535–8.
   PubMed Web of Science ®Google Scholar